NCT06492759 High Dose Radiation Therapy With Pembrolizumab and Chemotherapy for the Treatment of Patients With PD-L1 Positive Metastatic Triple Negative Breast Cancer Status RECRUITING Phase PHASE2
NCT06489808 Linperlisib Combined With Immunochemotherapy in Relapsed/Refractory LBCL Status RECRUITING Phase PHASE2
NCT06483282 A Study of Adebrelimab Combined With Apatinib Mesylate and Chemotherapy for Neoadjuvant Therapy and Biomarker Analysis in Limited-stage Small Cell Lung Cancer Status RECRUITING Phase PHASE2
NCT06480864 Adebrelimab Plus Apatinib for Maintenance Therapy of Extensive Stage Small Cell Lung Cancer Status RECRUITING Phase NA
NCT06478264 A Study of Adebrelimab Combined With Chemoradiotherapy in the Treatment of Esophageal Small Cell Carcinoma Status NOT_YET_RECRUITING Phase PHASE2
NCT06477523 Phase 1b/2 Study of LDRT in Combination With AK104 Plus Chemotherapy as First-line Treatment for ES-SCLC Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT06476184 Utility of Adjusting Chemotherapy Dose & Dosing Schedule With the SALVage Weekly Dose-dense Regimen in Patients With Poor Prognostic OVARian Cancers Based on the Tumor Unfavorable Primary Chemosensitivity and Incomplete Debulking Surgery Status RECRUITING Phase PHASE3
NCT06470243 Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body Status RECRUITING Phase PHASE3
NCT06457503 A Study of Toripalimab in Combination With Cisplatin and Gemcitabine in Participants With Recurrent Metastatic Nasopharyngeal Cancer Status RECRUITING Phase PHASE4
NCT06452277 A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2) Status RECRUITING Phase PHASE3
NCT06449222 Safety and Preliminary Effectiveness of BNT327, an Investigational Therapy for Breast Cancer, When Given in Combination With Chemotherapy Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06449209 Safety, Preliminary Effectiveness of BNT327, an Investigational Therapy for Patients With Small-cell Lung Cancer in Combination With Chemotherapy Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06448754 Volrustomig Priming Regimens Exploratory Phase II Platform Study Status RECRUITING Phase PHASE2
NCT06439225 Platinum and Taxane Chemo in Met Castration Resistant Prostate Cancer Patients With Alterations in DNA Damage Response Genes Status RECRUITING Phase PHASE3
NCT06431633 Study of Treatment With Sacituzumab and Zimberelimab for Patients With Lung Cancer Confined to the Chest and Previously Operated on Who Were Not Disease-free. Status RECRUITING Phase PHASE3
NCT06422143 Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023] Status RECRUITING Phase PHASE3
NCT06419673 Serplulimab Plus Chemoradiotherapy for Stage III-IVA Cervical Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06417814 A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer Status RECRUITING Phase PHASE3
NCT06416410 JAB-21822 Combined With JAB-3312 Compared SOC in the First Line for Treatment of Advanced Non-small Cell Lung Cancer With KRAS p.G12C Mutation Status RECRUITING Phase PHASE3
NCT06413992 Camrelizumab Plus Fluzoparib for TP-53 Mutated Endometrial Cancer Status RECRUITING Phase PHASE2